glioblastoma

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

glioblastoma
Mar 30, 2025, 06:28 | Blog
Anirban Maitra: Pancreatic cancer and glioblastoma deserve more investment, not funding cuts
Anirban Maitra, Scientific Director of the Sheikh Ahmed Pancreatic Cancer Research Center, shared a post…
Mar 24, 2025, 18:15 | Blog
Could CAR-T therapy change the treatment landscape for glioblastoma? - Video Journal of Oncology
Video Journal of Oncology (VJOncology) shared a post on LinkedIn: "March is Brain Tumor Awareness…
Mar 20, 2025, 08:00 | Insight
Suppressing Key Protein May Unlock Immunotherapy for Glioblastoma
ZNF638 inhibition triggers “viral mimicry,” making tumors more susceptible to treatment. Glioblastoma has remained one…
Mar 12, 2025, 09:01 | Science
Giuseppe Lombardi: Bevacizumab in recurrent glioblastoma - does dose matter?
Giuseppe Lombardi, Head of the Neuro-Oncology Unit at the Veneto Institute of Oncology, shared a…
Mar 11, 2025, 07:27 | Blog
Giuseppe Lombardi: A 122% increase in glioblastoma cases in the last 20 years
Giuseppe Lombardi, Head of the Neuro-Oncology Unit at the Veneto Institute of Oncology, shared a…
Mar 10, 2025, 13:21 | Science
Rasha Aboelhassan: The role of molecular and genetic profiling in revolutionizing glioblastoma treatment
Rasha Aboelhassan, Senior Oncology Consultant at Nasser Institute Hospital, shared an article by Moustafa A.…
Mar 7, 2025, 01:18 | Immune Oncology
Immunotherapy for Brain Cancer: Types, Success Rate, Side Effects and More
Brain cancer, particularly aggressive forms like glioblastoma, remains one of the most challenging malignancies to…
Mar 3, 2025, 11:37 | Science
Gustavo Viani: Triple Checkpoint Blockade as Neoadjuvant Therapy in Glioblastoma
Gustavo Viani, Professor of Radiation Oncology at Ribeirão Preto Medical School, shared a post on…
Feb 20, 2025, 09:27 | Science
Patrick Hwu: How can we treat solid tumor such as glioblastoma with T-cell therapy?
Patrick Hwu, President and CEO of Moffitt Cancer Center, shared a post on LinkedIn about…
Feb 13, 2025, 08:15 | Insight
Our first hypofractionated glioblastoma multiforme treatment - UTSW Radiation Oncology
UTSW Radiation Oncology shared a post on X: "This week, we delivered our first hypofractionated…
Feb 12, 2025, 08:08 | Science
Georgios Giamas: Advances in spatial biology techniques and their implementation in glioblastoma
Georgios Giamas, Professor of Cancer Cell Signalling at University of Sussex, shared an article by…
Jan 31, 2025, 15:06 | Blog
Yan Leyfman: Comparing CAR T Cells, CAR NK Cells and CAR Macrophages in Glioma Therapy
Yan Leyfman, Co-founder and executive director of MedNews Week, posted on LinkedIn about recent paper…
Jan 10, 2025, 17:52 | Insight
UCLA Study Reveals Endocan as a Key Target to Combat Glioblastoma's Growth and Therapy Resistance
New insight into how blood vessel-tumor interactions fuel glioblastoma can help lead to new strategies to…
Jan 8, 2025, 13:31 | Science
ESTRO/EANO recommendation on reirradiation of glioblastoma
ESTRO shared a post on X: "Check out the ESTRO/EANO recommendation on reirradiation of glioblastoma recently…
Jan 3, 2025, 19:42 | Insight
ESTRO/EANO Guidelines on Reirradiation of glioblastoma
Gustavo Viani, Professor of Radiation Oncology at Ribeirão Preto Medical School, shared a post on…
Jan 1, 2025, 16:24 | Insight
Jason Sheehan: The role of angiogenesis inhibitors on glioblastoma management
Jason Sheehan, Professor of Neurosurgery at the University of Virginia, shared a post on X…
Nov 24, 2024, 08:47 | Blog
Richard Scolyer: 18 months glioblastoma-free – a journey of hope
Richard Scolyer, Senior Staff Specialist in Tissue Pathology and Diagnostic Oncology at Royal Prince Alfred…
Nov 24, 2024, 00:54 | Insight
UCLA study uncovers how aggressive brain tumor evades treatment and highlights a promising new strategy
A new precision medicine approach that combines genetic and functional profiling helps predict how glioblastoma…
Nov 16, 2024, 16:02 | Insight
Shahrin Ahmed: CAR-T cells as a new treatment for Glioblastoma
Shahrin Ahmed, Medical specialist in oncology at the Canadian Cancer Society, shared a post on…
Nov 12, 2024, 14:55 | Blog
Lissandra Dal Lago: Discussing Innovative endpoints for the development of new treatment strategies in Geriatric Oncology
Lissandra Dal Lago, Chair EORTC Older Adult Council at European Organisation for Research and Treatment of…
Nov 9, 2024, 11:23 | Blog
European Organisation for Research and Treatment of Cancer webinar on innovative study designs for older adults
EORTC - European Organisation for Research and Treatment of Cancer shared a post on LinkedIn:…
Oct 27, 2024, 10:56 | Insight
October 2024 Tip Sheet of Sylvester Comprehensive Cancer Center
This month’s tip sheet from Sylvester Comprehensive Cancer Center at the University of Miami Miller…
Oct 14, 2024, 12:57 | Blog
Tanja Obradovic: Genenta Science announces opening of the Temferon trial in mRCC
Tanja Obradovic shared a post on LinkedIn: ''Clinical development landscape in metastatic renal cell carcinoma…
Oct 12, 2024, 15:32 | Blog
Defne Bayik: The V Foundation supports efforts to identify effective immunotherapies in glioblastoma
Defne Bayik, Assist Prof at University of Miami, shared a post on X: '' Extremely grateful…
Oct 11, 2024, 17:15 | Blog
The conundrum of CD8+T cells in low antigenic tumours - Cell Stress and Immunity (CSI) Lab
Cell Stress & Immunity (CSI) Lab shared a post on X: "Happy to share this nice…
Oct 9, 2024, 18:07 | Opinion
EORTC - TMZ treatment in older patients with glioblastoma and a truly unmethylated MGMT promoter
EORTC - European Organisation for Research and Treatment of Cancer shared on LinkedIn: "We're excited to…
Oct 8, 2024, 17:17 | Insight
Elizabeth McKenna: Cell State Heterogeneity and Intercellular Transfer in glioblastoma
Elizabeth McKenna recently shared an article by Vamsi Mangena et al. published in Cancer Discovery.…
Oct 5, 2024, 12:40 | Insight
Sylvester Comprehensive Cancer Center Researchers Present Findings at ASTRO 2024
Radiation oncologists from Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School…
Oct 3, 2024, 08:13 | Insight
Sylvester study: MRI provides early warning system for glioblastoma growth
The research suggests this technology could one day guide rapid treatment adaptation during radiation therapy…
Sep 21, 2024, 14:18 | Blog
Aram Modrek and his team received a $600,000 V Foundation Scholar Award for their Decoding Glioblastoma Treatment Escape Mechanisms
USC Brain Tumor Center shared a post on X: ''The V Scholar Grant is a…
Sep 18, 2024, 13:04 | Insight
Frank A. Giordano: CXCL12 and VEGF Inhibition Glioblastoma
Frank A. Giordano, Chair Deptartement of Radiation Oncology at University Medical Center Mannheim, shared on…
Sep 12, 2024, 09:58 | Blog
Richard Scolyer: Managing a Brain Aneurysm while facing glioblastoma
Professor Richard Scolyer shared a post on X: "I’ve recently been having some more medical work…
Sep 2, 2024, 08:21 | Blog
Carrie Pfluke honor her mom's memory & help other families - Wilmot Cancer Institute
Wilmot Cancer Institute shared a post on X: "Carrie Pfluke says the Wilmot team provided…
Aug 27, 2024, 21:34 | Insight
Shahrin Ahmed: Addressing weaknesses in invasive brain cancer by utilizing ROBO1 CAR T cells
Shahrin Ahmed, Medical Specialist at the Canadian Cancer Society, shared a post on X: “Exploiting…
Aug 23, 2024, 13:52 | Blog
Richard Scolyer: My memoir written with Garry Maddox is coming out soon
Richard Scolyer, CoMed Director at Melanoma Institute Australia, shared on X: "News alert: my memoir…
Aug 15, 2024, 07:54 | Insight
Preclinical study by MD Anderson Cancer Center represents the first use of IL-21 NK cells in glioblastoma
NK cells expressing interleukin-21 show promising antitumor activity in glioblastoma cells Natural killer (NK) cells…
Aug 13, 2024, 13:23 | Insight
Mayra Shanley: Engineering NK cells with IL-21 for cellular therapy of glioblastoma
Mayra Shanley, Senior Research Scientist at MD Anderson Cancer Center, shared on X: "I am…
Aug 12, 2024, 13:55 | Insight
The first patient in the United States to undergo an experimental treatment for glioblastoma
Leslie Davis, CEO and President at UPMC, shared on LinkedIn: "Clinical trials bring hope to patients,…
Aug 11, 2024, 10:17 | Blog
Carl June about the potential of using CAR T therapy to treat glioblastoma - Penn Medicine
Penn Medicine shared a post on LinkedIn: "This year could see major breakthroughs in brain…
Aug 7, 2024, 01:44 | Insight
Celia Dobersalske: Tumour reactive T cells assembling in the proximal cranial bone of patients with glioblastoma
Celia Dobersalske shared a post on X: “Excited to share our new paper out in…
Aug 5, 2024, 05:34 | Dialogues
Unlocking the Immune System: Dr. Levisetti on Cue Biopharma's New Biologics
Matteo Levisetti, M.D is chief medical officer of CUE Biopharma which is a clinical-stage biopharmaceutical…
Jul 31, 2024, 08:59 | Dialogues
ASCO24 Updates: How Glioblastoma Responds to Dendritic Cell Vaccination?
The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest and most…
Jul 29, 2024, 10:41 | Blog
Viviana Vella: Grateful to present my work on Glioblastoma at the BNOS Conference in Cambridge
Viviana Vella, Research Fellow in Cancer Cell Signalling at University of Sussex, shared on LinkedIn: "Grateful…
Jul 28, 2024, 14:49 | Blog
Stimulating questions and discussion with Clark Chen
Wafik S. El-Deiry shared on LinkedIn: "Outstanding meeting yesterday afternoon of the CNS Cancer Translational…
Jul 28, 2024, 10:32 | Blog
Fabio Moraes: Honored to present grand rounds at University Health Network
Fabio Moraes shared on LinkedIn: "It was an honor to present grand rounds at University…
Jul 27, 2024, 23:04 | Blog
Kimryn Rathmell: I had the honor of speaking at the 6th annual Glioblastoma Awareness Day reception hosted by National Brain Tumor Society
Kimryn Rathmell shared a post by Terri Armstrong, Senior investigator in the Neuro-Oncology Branch of the Center…
Jul 23, 2024, 00:16 | Blog
Research brings hope, advancing Glioblastoma treatments - Mayo Clinic
Mayo Clinic’s shared a post on LinkedIn: “Globally, approximately 300,000 people are diagnosed each year…
Jul 21, 2024, 12:10 | Blog
invIOs selects lead candidate to IND-enable studies in glioblastoma and melanoma
invIOs GmbH (“invIOs”), a privately held biotechnology company developing novel therapies for cancer, announced that…
Jul 19, 2024, 12:40 | Blog
Dolphins Cancer Challenge and StacheStrong Partnership Advances Brain Cancer Research at Sylvester Comprehensive Cancer Center
A $1 million commitment supports glioblastoma studies at the new Sylvester Brain Tumor Institute. Dolphins…
Jul 19, 2024, 00:37 | Blog
Rachael Kittleson: I am raising awareness on GBM in honor of my daughter
Rachael Kittleson, Senior Director of Community at the National Brain Tumor Society, shared on LinkedIn:…
Jul 18, 2024, 07:19 | Blog
Glioblastoma Awareness Day!
GLIOMATCH posted on LinkedIn: "Today is Glioblastoma Awareness Day (GBM Day)  On 17 July 2024,…
Jul 17, 2024, 14:25 | Opinion
Impactful stats about Glioblastoma - National Brain Tumor Society
National Brain Tumor Society shared on X: "Glioblastoma (GBM) is the deadliest type of brain…
Jul 17, 2024, 05:15 | Blog
The critical role of caregivers in improving patient outcomes - We Trials
We Trials shared a post on X:  . "On Glioblastoma Awareness Day, we highlight the…
Jul 13, 2024, 04:45 | Positive
Richard Scolyer: No evidence of recurrence of my glioblastoma!
Richard Scolyer shared a post on X: “I couldn’t be happier that my MRI brain…
Jul 9, 2024, 01:11 | Insight
Richard Scolyer: Using my illness to push boundaries to obtain knowledge about glioblatoma
Richard Scolyer shared a post on X: “I’m proud of being able to use my…
Jul 8, 2024, 13:00 | Insight
MD Anderson Research Highlights
Featuring a novel drug for glioblastoma, resources to understand tumor evolution, a lower-dose radiation approach,…
Jul 7, 2024, 02:28 | Insight
Research on malignant brain tumors is evolving Sylvester Brain Tumor Institute
Sylvester Comprehensive Cancer Center shared on LinkedIn: "Research on malignant brain tumors is rising to…
Jul 4, 2024, 16:09 | Blog
A deep dive into immune responses to cancer vaccines plus immunotherapy - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn:  . "David Reardon, MD, is doing a…
Jul 3, 2024, 23:45 | Insight
A four-patient trial testing a unique type of mRNA cancer vaccine - NCI
National Cancer Institute (NCI) shared a post on LinkedIn: "Recent results from several small clinical…
Jun 26, 2024, 08:52 | Blog
Richard Scolyer: Amazing advances in medicine over the past half century
Richard Scolyer shared on X: "Medicine has made many amazing advances over the past half…
Jun 22, 2024, 09:52 | Dialogues
ASCO24 Updates: Is RANO classification the future of glioblastoma?
The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest and most…
Jun 21, 2024, 16:06 | Cancer Types
Glioblastoma in Children: What patients and caregivers should know about
What is Glioblastoma? Pediatric glioblastoma is a rare and aggressive brain tumor that primarily affects children. It accounts for approximately 3% of…
Jun 20, 2024, 14:08 | Cancer Types
Glioblastoma in Adults: What patients should know about
Glioblastoma, also known as glioblastoma multiforme, is the most aggressive and common type of primary…
Jun 19, 2024, 12:33 | Blog
Maria Babak: How Bevacizumab is revolutionizing treatment for multiple cancers
Maria Babak shared a post by CityU iGEM on LinkedIn: "Discover how Bevacizumab, a powerful cancer…
Jun 15, 2024, 06:57 | Blog
Zouina Sarfraz: I will be lead guest editing a special collection titled 'Towards Universal Cancer Care'
Zouina Sarfraz, Associate Editor at BMC, shared a post on LinkedIn: “I am pleased to announce that…
Jun 2, 2024, 15:19 | Societies
Wafik S. El-Deiry: This morning I wore my nerdy DNA double helix tie
Wafik S. El-Deiry recently shared a post on LinkedIn: "This morning I wore my nerdy…
Jun 1, 2024, 11:12 | Blog
Manmeet Ahluwalia: Beyond thrilled to receive the notice of Award of our second NIH/NCI R01, $3.4 million grant
Manmeet Ahluwalia, Chief of Medical Oncology, Deputy Director and Chief Scientific Officer of Miami Cancer…
May 30, 2024, 11:14 | Blog
Pallavi Tiwari: Stoked to receive the NOA for our new $3.4M NIH/NCI R01 project
Pallavi Tiwari, Associate Professor at the UW School of Medicine and Public Health, recently shared…
May 30, 2024, 02:01 | Blog
Wei Zhang: P21 and cancer
Wei Zhang, Director of Center for Cancer Genomics and Precision Oncology at Wake Forest Baptist…
May 27, 2024, 08:43 | Insight
Diane-Isis Nyob: A new video that explains the complex mode of action of our drug for glioblastoma
Diane-Isis Nyob, Senior Market Intelligence Analyst at Debiopharm International SA, recently shared a post by…
May 24, 2024, 14:50 | Insight
A new paper on VC-resist glioblastoma cell state out in Nature Communications
A groundbreaking new open-access paper was published in the prestigious journal, Nature Communications, titled "VC-resist…
May 24, 2024, 12:25 | Blog
Claude Bajada: We are thrilled to announce the upcoming launch of the BRIAN project
Claude Bajada, Senior Lecturer at the University of Malta, shared on LinkedIn: "We are thrilled…
May 23, 2024, 13:01 | Insight
A neural epigenetic signature is prognostic in patients with glioblastoma - Nature Medicine
Nature Medicine recently shared a post on X: "A neural epigenetic signature detectable via plasma…
May 20, 2024, 07:05 | Blog
Marcela Maus: Expanding our clinical research around CAR-T therapy
Marcela Maus, Director of Cellular Immunotherapy, MGH Cancer Center Associate Professor at Harvard Medical School,…
May 16, 2024, 09:15 | Blog
Richard Scolyer: No sign of recurrence of glioblastoma
Richard Scolyer, CoMedical Director at Melanoma Institute Australia, shared a post on X: "I had brain…
May 14, 2024, 09:19 | Blog
Vivek Subbiah: Picking that needle in haystack --> ROS1 fusion in Glioblastoma
Quoting Vivek Subbiah on X: “Picking that needle in haystack --> ROS1 fusion in Glioblastoma. Striking response…
May 11, 2024, 12:13 | Insight
Biagio Ricciuti: Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutants
Biagio Ricciuti, Medical Oncologist at Dana-Farber Cancer Institute, shared on X/Twitter: "Comprehensive mutational scanning of EGFR…
May 10, 2024, 17:31 | Blog
The Sylvester Brain Tumor Institute launched by Sylvester Comprehensive Cancer Center to Personalize Brain Cancer Treatment
Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine announced establishment…
May 7, 2024, 11:18 | Blog
Richard Scolyer: I had further experimental treatment for my 'brain cancer' glioblastoma
Richard Scolyer, Co-Medical Director at Melanoma Institute Australia, shared on X/Twitter: "On Monday, I had further…
Apr 13, 2024, 13:34 | Blog
Vivek Subbiah: An editorial describes the science behind one strategy using a CAR T cell
Vivek Subbiah shared on X/Twitter: "Most patients diagnosed with glioblastoma die within a year, so innovative…
Apr 8, 2024, 17:38 | Blog
Abhishek Garg: Excellent commentary on our recent study on innovative dendritic cell vaccines and how to overcome unanticipated resistance
Abhishek Garg, Head of the Laboratory of Cell Stress and Immunity (CSI) at KU Leuven,…
Apr 4, 2024, 06:45 | Insight
Anna Golebiewska: New findings on how glioblastoma educates tumor microenvironment,
Anna Golebiewska, Principal Investigator at NORLUX Lab at Luxembourg Institute of Health, shared on X/Twitter:…
Mar 31, 2024, 14:23 | Blog
Dana-Farber Cancer Institute: Five Dana-Farber scientists have been chosen to receive Wong Family Awards in Translational Oncology for fiscal year 2024
Dana-Farber Cancer Institute posted on LinkedIn: "Five Dana-Farber scientists have been chosen to receive Wong…
Mar 23, 2024, 14:45 | Insight
Article summaries by Erman Akkus: BMI and cancer prognosis and billiary tract cancer
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X/Twitter: 1. ''BMI, weight…
Mar 20, 2024, 22:29 | Positive
Richard Scolyer: Amazingly, my latest MRI brain scan shows no recurrence 10 months since my glioblastoma
Richard Scolyer, Co-medical director at the Melanoma Institute Australia, and Cojoint professor at the University of…
Mar 19, 2024, 20:14 | Blog
Vivek Subbiah: Nice to see CAR-T cells showing early signals of activity in Glioblastoma in a Phase 1
Vivek Subbiah shared a post on LinkedIn: "Nice to see CAR-T cells showing early signals of…
Mar 18, 2024, 09:48 | Insight
Wafik S. El-Deiry: Important preliminary signal of transient response in GBM with CAR-T cells
Wafik S. El-Deiry, Director of the Legorreta Cancer Center at Brown University, shared a post…
Mar 17, 2024, 15:26 | Blog
Bryan D. Choi: NEJM published our clinical study of a novel CART Cell in patients with Glioblastoma
Bryan D. Choi, Neurosurgeon and Scientist at Massachusetts General Hospital, posted on X/Twitter: "Today, NEJM…
Mar 17, 2024, 13:22 | Drugs
Lombardi Giuseppe: Prospective study on regorafenib in recurrent glioblastoma
Lombardi Giuseppe, Head of the Neuro-Oncology Unit at the Veneto Institute of Oncology, shared on…
Mar 13, 2024, 09:23 | Blog
Katy Rezvani: Important study showing the promise of locoregional delivery of CAR-T cells in glioblastoma
Katy Rezvani, Chief, Section of Cellular Therapy at the Department of Stem Cell Transplantation and…
Mar 12, 2024, 09:51 | Blog
Angela Mastronuzzi: Happy to share our multicenter retrospective study on a large cohort of GBM-LTS patients from nine Italian institutions
Angela Mastronuzzi shared on LinkedIn: “Happy to share our just published study! "Clinicopathological and molecular landscape…
Feb 19, 2024, 09:26 | Insight
Justin Stebbing: Amazing work to identify PANK4 as a major factor in resistance to routine treatment in one of the hardest-to-treat tumors, glioblastoma
Justin Stebbing shared on LinkedIn: "Huge congratulations to an amazing team led by Georgios Giamas,…
Jan 27, 2024, 07:20 | Blog
Richard Scolyer: Still no recurrence of my supposedly incurable glioblastoma!
Richard Scolyer, CoMedical Director at Melanoma Institute Australia and Surgical Pathologist at Royal Prince Alfred…
Jan 25, 2024, 17:25 | Insight
Radhika Mathur: Glioblastoma from a 3D whole-tumor perspective. My 5+ years of postdoctoral work
Radhika Mathur, Research Scientist at UCSF, recently shared on X/Twitter: "Thrilled to finally share my…
Jan 25, 2024, 08:51 | Insight
Vivek Subbiah: Tissue Agnostic Precision Medicine in Primary brain tumors like glioblastoma?
Vivek Subbiah shared on LinkedIn: "Hot off the press. What is the impact of Tissue Agnostic…
Jan 21, 2024, 07:28 | Insight
Abhishek Garg: Innovative reverse translational approach helped us discover a novel dual-organ immuno-resistance pathway
Abhishek Garg, Head of the Laboratory of Cell Stress and Immunity (CSI) at KU Leuven,…
Oct 7, 2023, 16:23 | Blog
We are delighted to announce the official start of LEGATO Project - EORTC - European Organisation for Research and Treatment of Cancer
The European Organisation for Research and Treatment of Cancer (EORTC), shared a post by LEGATO…
Sep 22, 2023, 18:38 | Insight
Angela Mastronuzzi: Proud of my team at Ospedale Pediatrico Bambino Gesù for this paper published with MDPI.
Angela Mastronuzzi, Head of Neuro-Oncology Unit at the Bambino Gesù Children's Hospital, shared on LinkedIn:…
Sep 19, 2023, 20:03 | Drugs
Gabriela Kramer-Marek: I have just presented the very first results of our recently initiated clinical study evaluating 89Zr-DFO-Atezolizumab in patients with newly diagnosed glioblastoma!
Sep 12, 2023, 19:42 | Career
Manmeet Ahluwalia: Congratulations Ahmad Ozair for the prestigious Rosenblum-Mahaley award!
Manmeet Ahluwalia, Chief Scientific Officer at the Miami Cancer Institute, shared a post by Ahmad…
12
All: 106 Posts: 1 - 100
Special Coverage